Venturi Wealth Management LLC increased its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 4,893.5% in the 3rd quarter, Holdings Channel.com reports. The firm owned 2,297 shares of the medical instruments supplier’s stock after acquiring an additional 2,251 shares during the quarter. Venturi Wealth Management LLC’s holdings in DENTSPLY SIRONA were worth $62,000 as of its most recent filing with the SEC.
Several other hedge funds have also recently added to or reduced their stakes in the business. UMB Bank n.a. lifted its holdings in shares of DENTSPLY SIRONA by 430.3% during the third quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock worth $25,000 after buying an additional 753 shares during the last quarter. Capital Performance Advisors LLP acquired a new position in DENTSPLY SIRONA during the 3rd quarter valued at $27,000. LRI Investments LLC boosted its holdings in DENTSPLY SIRONA by 82.7% in the 2nd quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock valued at $31,000 after purchasing an additional 564 shares during the period. Rothschild Investment LLC acquired a new stake in DENTSPLY SIRONA in the 2nd quarter worth $32,000. Finally, Kennebec Savings Bank bought a new position in shares of DENTSPLY SIRONA during the 3rd quarter worth about $35,000. Institutional investors own 95.70% of the company’s stock.
DENTSPLY SIRONA Stock Up 2.3 %
XRAY opened at $18.28 on Friday. The firm has a market cap of $3.63 billion, a price-to-earnings ratio of -8.83, a PEG ratio of 1.70 and a beta of 1.02. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The firm’s 50-day simple moving average is $23.92 and its 200-day simple moving average is $25.45. DENTSPLY SIRONA Inc. has a twelve month low of $17.21 and a twelve month high of $37.60.
Wall Street Analyst Weigh In
XRAY has been the topic of a number of recent research reports. Leerink Partners downgraded DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Thursday, November 7th. Needham & Company LLC decreased their price objective on DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating on the stock in a report on Friday, October 25th. Robert W. Baird cut their target price on DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating for the company in a research note on Friday, November 8th. Leerink Partnrs downgraded shares of DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research note on Thursday, November 7th. Finally, StockNews.com upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research note on Wednesday, November 6th. Six analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, DENTSPLY SIRONA presently has an average rating of “Hold” and an average price target of $29.50.
View Our Latest Analysis on XRAY
DENTSPLY SIRONA Profile
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Recommended Stories
- Five stocks we like better than DENTSPLY SIRONA
- What Do S&P 500 Stocks Tell Investors About the Market?
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- 5 Top Rated Dividend Stocks to Consider
- Top-Performing Non-Leveraged ETFs This Year
- What is Forex and How Does it Work?
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report).
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.